According to a study conducted by experts from Leeds University (UK), taking aspirin can prevent the development in patients of colon cancer. This property is known medication emerged during the experiment.
The results of the experiment showed that aspirin prevents colon cancer due to its ability to affect tumor cells, portal has published MedicalXPress. It turned out that is familiar to all drug is able to reduce the likelihood of patients of colon cancer, according to a press release.
Scientists have collected group of patients (700), which were found in the polyps of the intestinal mucosa, indicating increased risk of colon cancer. Volunteers were divided into groups that took aspirin, eicosapentaenoic acid (polyunsaturated fatty acid omega-3) or placebo. A year later, most successful indicators of the state of the intestines distinguished participants who drank the aspirin. In patients taking aspirin, the number of polyps decreased by 22% in the group taking fatty acid – only 9%.
“Aspirin effectively reduce the number of precancerous polyps of the intestinal mucosa in patients from the group with a high risk of bowel cancer” – summed up in the end, the authors of the study.
Eicosapentaenoic acid were also added to the list of means to prevent bowel cancer.
Prior to this, scientists of the Munich technical University have received evidence that the reason for the development of tumors of the large intestine may be the microflora inhabiting the lower gastrointestinal tract. In particular, as follows from their report, factor in the development of colon cancer can be the activity of ATF6 protein involved in cell stress.
Earlier Magicforum wrote about designed by experts, the analysis of blood to detect ovarian cancer at an early stage.